Shilpa Medicare: Update on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary…
Shilpa Medicare (SHILPAMED) filed a disclosure titled "Update on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited". The company is valued at about ₹18,229 crore.
What happened
Shilpa Medicare (SHILPAMED) filed a disclosure with the exchanges on 5 November 2026 at 04:44 PM titled "Update on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited".
Company snapshot
Shilpa Medicare is a small-cap company in the Healthcare sector, with a market value of about ₹18,229 crore.
The stock last traded at ₹932.1, against a 52-week range of ₹259.5–₹1,095 (14.9% below the high).
Before this filing the shares had moved −12.4% over the month and +44.6% over three months. Average daily turnover over the last 20 sessions was about ₹74.76 crore.
Promoters held 40.13% at the end of Q1 FY27; 8.73% of promoter shares were pledged. Foreign institutions owned 11.38% and domestic institutions 8.05%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 321 | 46.9 | 4.79 |
| Q2 FY26 | 370 | 44.1 | 2.25 |
| Q3 FY26 | 410 | 44.6 | 2.36 |
| Q4 FY26 | 437 | 107.8 | 5.51 |
| Q1 FY27 | 466 | 100.9 | 5.16 |
What history shows
This is not the company's first litigation disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Across 22 similar disclosures by other Healthcare companies, shares moved −0.4% on average the next day and −0.0% over five days; 32% of them rose the next day.
Market-wide, 644 litigation filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 37% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- 5 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Shilpa Medicare Limited (SHILPAMED.BO) Seasonal Returns Chart - Yahoo Finance
- Shilpa Medicare secures Europe GMP approval for Jadcherla Unit 4
- Shilpa Medicare - Technical picks for Diwali! 10 stocks PL Capital is bullish on this festive season. See full list
- Shilpa Medicare SHILPAMED Q2 FY27 Earnings Call Nov 2026
- Shilpa Medicare reports strong H1 FY27 consolidated profit
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.